Blood pressure
hypertension
SECONDARY, HYPERTENSION, CONCOMITANT DISEASE
At baseline, the mean (SD) SBP was 152.59 (23.44) mmHg in the intervention group and 148.85 (20.70) mmHg among controls. After 12 weeks of follow-up, the mean (SD) SBP decreased by 8.52 (19.73) mmHg in the intervention group and by 1.25 (12.47) mmHg in the control group (between-group difference, −7.265 mm Hg; 95% CI, −12.89 to −1.64 mm Hg; Primary and secondary outcomes.Subgroup analyses of the association of the intervention with SBP by gender, age, number of concomitant diseases, years of hypertension, baseline BMI, baseline hypertension compliance and baseline self-efficacy showed no significant between-group differences, while was significant by baseline SBP (